InvestSMART

AdAlta Limited (ASX: 1AD) - Announcements

- Current share price for 1AD : $0.003

ASX company news and announcements for AdAlta Limited (1AD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All AdAlta Limited (1AD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than AdAlta Limited (1AD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for AdAlta Limited (1AD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$10 Appendix 3B 23 Feb 2017 8:28AM $0.225 $0.003 fallen by 98.67%
$10 Fibrosis symposium presentation 21 Feb 2017 8:18AM $0.200 $0.003 fallen by 98.50%
$10 Half Yearly Report and Accounts 14 Feb 2017 5:23PM $0.210 $0.003 fallen by 98.57%
$10 Release of Securities from Escrow 1 Feb 2017 12:19AM $0.210 $0.003 fallen by 98.57%
$10 Appendix 4C - quarterly 31 Jan 2017 8:24AM $0.205 $0.003 fallen by 98.54%
$10 AdAlta receives Orphan Designation for AD-114 18 Jan 2017 11:53AM $0.180 $0.003 fallen by 98.33%
$10 Updated Company Presentation 17 Jan 2017 2:36PM $0.180 $0.003 fallen by 98.33%
$10 Positive Pre-clinical Data 9 Jan 2017 8:24AM $0.185 $0.003 fallen by 98.38%
$10 Appendix 3B 21 Dec 2016 7:35PM $0.180 $0.003 fallen by 98.33%
$10 Initial Director's Interest Notice 15 Nov 2016 9:46AM $0.225 $0.003 fallen by 98.67%
$10 Director Appointment 15 Nov 2016 8:26AM $0.225 $0.003 fallen by 98.67%
$10 Results of Meeting 14 Nov 2016 3:26PM $0.225 $0.003 fallen by 98.67%
$10 AGM Presentation 14 Nov 2016 1:27PM $0.225 $0.003 fallen by 98.67%
$10 Commercialisation Agreement with Crossbeta Biosciences 8 Nov 2016 9:24AM $0.180 $0.003 fallen by 98.33%
$10 Change of Director's Interest Notice 7 Nov 2016 7:27PM $0.180 $0.003 fallen by 98.33%
$10 Appendix 3B 7 Nov 2016 7:26PM $0.180 $0.003 fallen by 98.33%
$10 Collaboration Agreement with XL-Protein 7 Nov 2016 7:10PM $0.180 $0.003 fallen by 98.33%
$10 Quarterly Review and Appendix 4C 27 Oct 2016 8:24AM $0.205 $0.003 fallen by 98.54%
$10 Change of Director's Interest Notice 21 Oct 2016 6:38PM $0.220 $0.003 fallen by 98.64%
$10 Appendix 3B 21 Oct 2016 6:37PM $0.220 $0.003 fallen by 98.64%
$10 AdAlta to present at forthcoming industry conferences 19 Oct 2016 2:32PM $0.230 $0.003 fallen by 98.70%
$10 Update on Orphan Drug Designation Application 14 Oct 2016 8:25AM $0.220 $0.003 fallen by 98.64%
$10 Notice of Annual General Meeting/Proxy Form 4 Oct 2016 11:11AM $0.245 $0.003 fallen by 98.78%
$10 Change of Director's Interest Notice 27 Sep 2016 11:16AM $0.240 $0.003 fallen by 98.75%
$10 Change of Director's Interest Notice 27 Sep 2016 11:11AM $0.240 $0.003 fallen by 98.75%

676 - 700 of 737 results

Page 28 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.